...
首页> 外文期刊>Journal of Nutritional Science and Vitaminology >Formation of [ Nicotinamide -2H3]NAD+ from [2H4]Nicotinamide and [2H4]Nicotinic Acid in Human HepG2N Cells and Involvement of 2H/1H Exchange at the Redox Site of NAD+/NADH
【24h】

Formation of [ Nicotinamide -2H3]NAD+ from [2H4]Nicotinamide and [2H4]Nicotinic Acid in Human HepG2N Cells and Involvement of 2H/1H Exchange at the Redox Site of NAD+/NADH

机译:由[ 2 H 4 形成[烟酰胺- 2 H 3 ] NAD + >]人HepG2N细胞中的烟酰胺和[ 2 H 4 ]烟酸和 2 H / 1 的参与NAD + / NADH的氧化还原位处的H交换

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To determine the rates of cellular NAD+ synthesis and breakdown, incorporation of stable isotope-labeled precursors into NAD+ should be quantified. Although with 2H (D)-labeled precursors [2,4,5,6-D4]nicotinamide ([D4]Nam) and [2,4,5,6-D4]nicotinic acid ([D4]NA), [D3]NAD+ is formed in human cells, why only three of four D atoms from [D4]Nam and [D4]NA are present in NAD+ remains unknown. Using a liquid chromatography-tandem mass spectrometry, we tested the involvement of D/1H (H) exchange at the redox site of NAD+/NADH (C-4 carbon of the pyridine ring) by oxidoreductases exhibiting opposite stereospecificity for the coenzymes in the 1-Da mass decrease in the cellular NAD+ formation. In all cells examined, [ Nam -D3]NAD+, but not [ Nam -D4]NAD+, was obtained after the incubation with the D4-labeled precursors, whereas [ Nam -D4]NAD+, but not [ Nam -D3]NAD+, was synthesized from the same precursors with purified recombinant NAD+ biosynthetic enzymes. [D4]Nam group of [ Nam -D4]NAD+ was converted to [D3]Nam group via [D4]NADH by in vitro sequential reduction and oxidation with oxidoreductases exhibiting opposite stereospecificity for the coenzymes. Furthermore, using [2,5,6-D3]Nam, which has H instead of D at the C-4 carbon, as a precursor of NAD+ in the cells, the 1-Da mass decrease in the nucleotide was not observed. Based on these observations, we conclude that following the synthesis of [ Nam -2,4,5,6-D4]NAD+, cellular redox reactions of NAD+/NADH convert [ Nam -2,4,5,6-D4]NAD+ to [ Nam -2,5,6-D3]NAD+. Quantification of [ Nam -2,5,6-D3]NAD+ and [2,5,6-D3]Nam would successfully determine the rate of the NAD+ turnover and provide clues to understand regulatory mechanisms of cellular NAD+ concentrations.
机译:为了确定细胞NAD + 的合成和分解速率,应定量将稳定同位素标记的前体掺入NAD + 中。尽管带有 2 H(D)标记的前体[2,4,5,6-D 4 ]烟酰胺([D 4 ] Nam )和[2,4,5,6-D 4 ]烟酸([D 4 ] NA),[D 3 ] NAD + 在人体细胞中形成,为什么在[D 4 ] Nam和[D 4 ] NA中只有四个D原子存在NAD + 仍然未知。使用液相色谱-串联质谱法,我们测试了D / 1 H(H)交换在NAD + / NADH(C-4碳在细胞内NAD + 的形成过程中,氧化还原酶对1-Da质量的辅酶显示相反的立体特异性。在所有检查的单元格中,[Nam -D 3 ] NAD + ,而不是[Nam -D 4 ] NAD + 是在与D 4 标记的前体孵育后获得的,而[Nam -D 4 ] NAD + ,但没有[用纯化的重组NAD + 生物合成酶从相同的前体合成Nam -D 3 ] NAD + 。 [Nam -D 4 ] NAD + 的[D 4 ] Nam组被转换为[D 3 ]通过[D 4 ] NADH的Nam基团在体外顺序还原并用氧化还原酶氧化,对辅酶表现出相反的立体特异性。此外,使用[2,5,6-D 3 ] Nam(在C-4碳原子上具有H而不是D)作为NAD + 中的前体。在细胞中,未观察到核苷酸的1-Da质量下降。基于这些观察,我们得出结论,在合成[Nam -2,4,5,6-D 4 ] NAD + 之后,NAD + / NADH将[Nam -2,4,5,6-D 4 ] NAD + 转换为[Nam -2,5,6-D 3 ] NAD + 。定量[Nam -2,5,6-D 3 ] NAD + 和[2,5,6-D 3 ] Nam即可成功地确定了NAD + 转换的速率,并为了解细胞NAD + 浓度的调节机制提供了线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号